Olivier Pomel - Jan 13, 2025 Form 4 Insider Report for Datadog, Inc. (DDOG)

Signature
/s/ Kerry Acocella, Attorney-in-Fact
Stock symbol
DDOG
Transactions as of
Jan 13, 2025
Transactions value $
-$16,277,944
Form type
4
Date filed
1/15/2025, 04:24 PM
Previous filing
Dec 20, 2024
Next filing
Jan 29, 2025

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DDOG Stock Option (Right to Buy) Options Exercise $0 -150K -16.67% $0.00 751K Jan 13, 2025 Class B Common Stock 150K $0.31 Direct F7, F8
transaction DDOG Class B Common Stock Options Exercise $0 +150K +1.79% $0.00 8.55M Jan 13, 2025 Class A Common Stock 150K Direct F1
transaction DDOG Class B Common Stock Conversion of derivative security $0 -85.6K -1% $0.00 8.47M Jan 13, 2025 Class A Common Stock 85.6K Direct F1
transaction DDOG Stock Option (Right to Buy) Options Exercise $0 -38.1K -2.94% $0.00 1.26M Jan 13, 2025 Class B Common Stock 38.1K $0.91 Direct F7
transaction DDOG Class B Common Stock Options Exercise $0 +38.1K +0.45% $0.00 8.51M Jan 13, 2025 Class A Common Stock 38.1K Direct F1
transaction DDOG Class B Common Stock Conversion of derivative security $0 -21.7K -0.26% $0.00 8.49M Jan 13, 2025 Class A Common Stock 21.7K Direct F1
transaction DDOG Class B Common Stock Conversion of derivative security $0 -11.2K -0.13% $0.00 8.47M Jan 13, 2025 Class A Common Stock 11.2K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.
F2 Shares sold pursuant to a 10b5-1 plan dated September 13, 2024.
F3 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $136.72 to $137.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $137.72 to $138.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $138.73 to $139.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $139.76 to $139.85. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7 Option is fully vested and exercisable.
F8 The expiration date of 06/28/2029 was inadvertently reflected in the Reporting Person's prior Form 4 filings for this option grant.